Antimicrobial therapies for Q fever
- PMID: 24073941
- PMCID: PMC4608426
- DOI: 10.1586/14787210.2013.840534
Antimicrobial therapies for Q fever
Abstract
Q fever is caused by the bacterium Coxiella burnetii and has both acute and chronic forms. The acute disease is a febrile illness often with headache and myalgia that can be self-limiting, whereas the chronic disease typically presents as endocarditis and can be life threatening. The normal therapy for the acute disease is a 2 week course of doxycycline, whereas chronic disease requires 18-24 months of doxycycline in combination with hydroxychloroquine. Alternative treatments are used for pregnant women, young children and those who cannot tolerate doxycycline. Doxycycline resistance is rare, but has been reported. Co-trimoxazole is a currently recommended alternative treatment, but quinolones, rifampin and newer macrolides may also provide some benefit.
References
-
- McQuiston JH, Childs JE. Q fever in humans and animals in the United States. Vector Borne & Zoonotic Diseases. 2002;2(3):179–191. - PubMed
-
- Hatchette T, Campbell N, Hudson R, Raoult D, Marrie TJ. Natural history of Q fever in goats. Vector Borne Zoonotic Dis. 2003;3(1):11–15. - PubMed
-
- van der Hoek W, Dijkstra F, Schimmer B, et al. Q fever in the Netherlands: an update on the epidemiology and control measures. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 2010;15(12) - PubMed
-
- Voth DE, Heinzen RA. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cellular microbiology. 2007;9(4):829–840. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources